Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates.
about
A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in miceInduction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.Development of peptide mimics of a protective epitope of Vibrio cholerae Ogawa O-antigen and investigation of the structural basis of peptide mimicry.Identification and characterization of peptide mimics of blood group A antigen.Peptide-displaying phage technology in glycobiologySynthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvantsDevelopment of a lipopolysaccharide-targeted peptide mimic vaccine against Q feverPotential of peptides as inhibitors and mimotopes: selection of carbohydrate-mimetic peptides from phage display libraries.Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.Carbohydrate-mimetic peptides: structural aspects of mimicry and therapeutic implications.Current and Future Prospects for a Vaccine for Nontypeable Haemophilus influenzae.Mapping protective regions on a three-dimensional model of the Moraxella catarrhalis vaccine antigen, Oligopeptide Permease A.Potential targets for next generation anti-microbial glycoconjugate vaccines.Antibody reactivity of conformational peptide mimics of a conserved H5N1 neutralization site in different fusion proteinsParticle size and zeta potential investigation of synthetic peptide-protein conjugates / Sentetik peptid-protein konjugatlarının parçacık boyutu ve zeta potensiyel analizi
P2860
Q31137207-45BB7B64-4D8E-410E-8A2D-F1D26DF98F78Q33237828-2848AA1B-C014-4B47-9840-6D83539C4045Q33299645-8D948E5B-7F4A-45EA-84D7-6DD6174F43C4Q33334832-5AD806AA-11DB-4749-B5C0-35C6CB45E052Q34022620-D5E1884D-4F19-404F-AEFC-1DB33D8E00F4Q34170285-B934E96D-9E67-4843-A100-5E3A8FDA57A2Q34440031-E139D781-8AE9-444D-8272-8EEA47F43CB3Q34456700-45B8A920-6BCC-41C9-94B5-30567BD9021BQ35548019-21D3B06C-490E-4095-9992-5F8CF09D4709Q35987717-B1DDA135-019F-425A-9AB5-F3D7AD4A15E8Q37827163-06CBB8C6-9846-4B29-A2C5-31F7C993B92FQ39987614-4E6298C3-4E69-487D-A6FB-E24B726BA317Q47332587-1A29BA4A-1917-4D01-95AD-E6A99FC98D23Q53701548-4885F684-0F6D-4E2A-B5B3-54B17F29C25AQ57262037-8A888FA7-E70C-4DB4-9353-152BFDB3AA03Q57381698-15A0802E-727A-4D88-B383-44ABECEBD235
P2860
Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Development of peptide mimotop ...... luenzae as vaccine candidates.
@ast
Development of peptide mimotop ...... luenzae as vaccine candidates.
@en
type
label
Development of peptide mimotop ...... luenzae as vaccine candidates.
@ast
Development of peptide mimotop ...... luenzae as vaccine candidates.
@en
prefLabel
Development of peptide mimotop ...... luenzae as vaccine candidates.
@ast
Development of peptide mimotop ...... luenzae as vaccine candidates.
@en
P1476
Development of peptide mimotop ...... luenzae as vaccine candidates.
@en
P2093
Xin-Xing Gu
Yingchun Hou
P304
P356
10.4049/JIMMUNOL.170.8.4373
P407
P577
2003-04-01T00:00:00Z